Tag: Association for Ocular Pharmacology

Cataracts are a global economic and social burden that is increasing with our ageing population. Since surgery is currently the only treatment, preventative pharmacological interventions are needed. Antioxidants and aldose reductase inhibitors (ARIs) can tackle oxidative and osmotic stress, which are the main causes of age related and diabetic cataracts, respectively. In the veterinary market, a topical nutraceutical formulation has […]

Read More… from Potential breakthrough in cataract treatment